Contact
Please use this form to send email to PR contact of this press release:
Sethera Therapeutics Releases New Paper Introducing Enzymatic Macrocyclization Platform to Upgrade GLP 1 Peptides
TO:
Karsten Eastman
Sethera Therapeutics, Inc.
+1 801-850-4367